← Back to all trials
Completed
NCT05892770
Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia
Conditions: Spasmodic Dysphonia
Sex: All
Ages: 18 Years – 99 Years
Healthy volunteers: Yes
Phase: PHASE1, PHASE2
Enrollment: 32
Sponsor: University of Florida
Location: University of Florida- Shands Hospital Gainesville Florida
Summary
One initial study has shown that Botulinum Toxin (BT) in combination with zinc supplementation may increase the duration of effects BT treatment. This initial study was in the context of facial aesthetics. The purpose of the present study is to determine the effect, if any, of oral zinc supplementation prior to BT in the treatment of spasmodic dysphonia. If positive effects will be observed, this would help reduce the burden of disease for these patients.
Eligibility Criteria
Inclusion Criteria:
* Adults patients
* 18 years old and above
* Current diagnosis of ADductor spasmodic dysphonia
* Has had Botox injection treatments for SD \> 6 months
Exclusion Criteria:
* Pregnant
* Diagnosis of ABductor spasmodic dysphonia
* Patients taking \> 30 mg zinc supplementation daily prior to study beginning
Source: ClinicalTrials.gov (NCT05892770). StuddyBuddy aggregates publicly available trial information.
